Vaccine tested to stop shingles from coming back
NCT ID NCT04091451
Summary
This study tested whether a two-dose shingles vaccine could safely prevent a second painful shingles outbreak in adults aged 50 and older who had already experienced shingles. Over 1,400 participants received either the vaccine or a placebo shot to compare recurrence rates and side effects. The main goal was to see if the vaccine reduced new shingles cases and to check how the body's immune system responded.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Barnaul, 656043, Russia
-
GSK Investigational Site
Gatchina, 188300, Russia
-
GSK Investigational Site
Moscow, 115478, Russia
Conditions
Explore the condition pages connected to this study.